Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Bon Natural Life Limited's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Bon Natural Life Limited (BON) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2025
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-22.64 %
Q4 2025
Net Margin
-11.46 %
Q4 2025

Key Findings: Bon Natural Life Limited vs Its Competitors

  • TTM: Trailing 12-month revenue of 18M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
  • Peer revenue share: Bon Natural Life Limited accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

BON Sales vs. its Competitors, Q4 2025

Bon Natural Life Limited generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/BON/competitors
https://api.csimarket.com/api/v1/companies/BON/relationships
https://api.csimarket.com/api/v1/companies/BON/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Legal Cannabis industry grew revenue 34.7% year over year, combined, vs -22.6% for Bon Natural Life Limited. Bon Natural Life Limited's share of combined industry revenue moved from 0.97% to 0.56%, a loss of 0.41 percentage points.

Bon Natural Life Limited's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Bon Natural Life Limited No No No Yes
High-Confidence Competitors (1) 0% 100% 100% 0%
Similar Growth & Profitability (8) 0.00 % (0 of 8) 37.50 % (3 of 8) 25.00 % (2 of 8) 40.00 % (2 of 5)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2025

100%market share
  • Bon Natural Life Limited100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Bon Natural Life Limited and its 0 tracked competitors.

See Bon Natural Life Limited's full market share breakdown »

BON Stock Performance relative to its Competitors

BON Competitors (weighted) Percent change over the selected range

Bon Natural Life Limited's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
100%beat U.S.A. 500
High-Confidence
(1 of 1)
0%beat U.S.A. 500
Similar Growth & Profitability
(0 of 2)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Bon Natural Life Limited -39.70 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (1) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (2) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Bon Natural Life Limited's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

BON Stock Performance relative to High-Confidence Competitors

BON High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

BON Stock Performance relative to Similar Growth & Profitability Competitors

BON Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Bon Natural Life Limited's Comment on Competition and Industry Peers

The company's main competitors operate in the Big Health industry, supplying functional ingredients, nutrition food, and traditional Chinese medicine functional food. Notably, Chenguang Biotech (CCGB), a leading natural ingredients supplier in China with twenty subsidiaries, focuses on natural colors, spice extracts, essential oils, nutrition, medicinal extracts, and protein oils. Competitors generally possess advantages such as larger business scale, stronger capital strength, more extensive and comprehensive sales networks, and higher brand recognition, often as established public companies with longer development histories. The company distinguishes itself by utilizing advanced bio-manufacturing technologies, whereas competitors primarily rely on traditional physical and chemical methods like extraction and separation. For example, in ambroxide production, competitors typically employ chemical synthesis involving lengthy and complex processes.

Bon Natural Life Limited's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Quantum Hi-Tech (China) Biotechnology Co., Ltd. Named by the company 85% 2022 to 2026 3
Chenguang Biotech (CCGB) Named by the company 85% 2022 to 2026 3
QHT Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Bon Natural Life Limited's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.